SCCmec amplification as a mechanism for ceftobiprole resistance in clinical MRSA isolates
Feiteng Zhu,Hemu Zhuang,Lingfang Di,Zhengan Wang,Yiyi Chen,Shengnan Jiang,Chao Gu,Lu Sun,Haiping Wang,Yiwei Zhu,Peng Lan,Dandan Wu,Yunsong Yu,Shujuan Ji,Yan Chen
DOI: https://doi.org/10.1016/j.cmi.2022.03.009
IF: 13.31
2022-04-01
Clinical Microbiology and Infection
Abstract:ObjectivesIn this study, we evaluated the Ceftobiprole (BPR) susceptibilities of 472 Methicillin-resistant Staphylococcus aureus (MRSA) isolates and investigated the mechanisms underlying BPR resistance.MethodsFor all MRSA isolates, BPR minimum inhibitory concentration (MIC) was determined by agar dilution. We sequenced the BPR resistant isolates through Illumina short-read sequencing and MinION long-read sequencing. We also selected MRSA isolates of ST5, ST59 and ST239 and exposed them in increasing BRP concentrations. The mutants isolated developing BPR resistance were sequenced.Results471 MRSA isolates were susceptible to BPR, with MICs ranging from 0.25 to 2 mg/L. As compared to HA-MRSA isolates (MIC50 = 2 mg/L, MIC90 = 2 mg/L), CA-MRSA isolates (MIC50 = 0.5, MIC90 = 2 mg/L) were more susceptible to BPR (p<0.001). Compared to isolates with SCCmec type II or type III (MIC50 = 2 mg/L, MIC90 = 2 mg/L), isolates with SCCmec type IV (MIC50 = 1 mg/L, MIC90 = 1 mg/L) or V (MIC50 = 0.5 mg/L, MIC90 = 1 mg/L) were more susceptible to BPR (p<0.001). Nanopore sequencing revealed 2 copies of SCCmec repeats in the BPR-resistant MRSA isolate. In addition, SCCmec amplification could be induced by BPR exposure in ST239 MRSA isolates; however, no amplification was observed in the other lineages. The induced BPR-resistant MRSA isolates also acquired mutations in mecA and other genes such as guaA, guaB, relA, rpoA, and oatA, which were speculated as factors contributing to BPR-resistance development.ConclusionsWe concluded that BPR showed significant antibacterial activity against MRSA isolates in China, however, the emergence of a BPR-resistant isolate before its launch was a cause for concern. Multiple genes and pathways are potentially involved in the development of BPR resistance in MRSA, and our data demonstrated the role of nanopore-sequencing in revealing the tandem repeat-mediated resistance mechanism in MRSA.
infectious diseases,microbiology